Larvol Delta - SilkTech-Biopharmaceuticals-completes-enrollment-of-phase-2B-clinical-trial-of-SDP4-for-the-treatment-of-the-signs-and-symptoms-of-dry-eye-disease

SDP-4 - SilkTech

http://clinicaltrials.gov/ct2/show/NCT04535947

May 17, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next